OrganiGram Holdings Inc. through a subsidiary is a licensed producer of medical marijuana. The stock set a 52-week low of $0.195 on Oct. 7, but its fortunes appear to have pivoted since it started to become clear that the Liberals were moving ahead in the polls prior to the election. The stock is up 81.5 per cent since Oct. 7, and insiders have been buying as the share price has recovered. In particular, we note that since Sept. 25, chief executive officer Denis Arsenault acquired 107,100 shares at an average price of $0.30.
Ted Dixon is CEO of INK Research, which provides insider news and knowledge to investors. For more background on insider reporting in Canada, visit the FAQ section. Securities referenced in this profile may have already appeared in recent reports distributed to INK subscribers. INK staff may also hold a position in profiled securities.
Infographic reflects public-market transactions of common shares or unit trusts by company officers and directors.